169 related articles for article (PubMed ID: 31625097)
1. Selection and Characterization of Anti-idiotypic Shark Antibody Domains.
Könning D; Zielonka S; Kaempffe A; Jäger S; Kolmar H; Schröter C
Methods Mol Biol; 2020; 2070():191-209. PubMed ID: 31625097
[TBL] [Abstract][Full Text] [Related]
2. Generation of Semi-Synthetic Shark IgNAR Single-Domain Antibody Libraries.
Grzeschik J; Könning D; Hinz SC; Krah S; Schröter C; Empting M; Kolmar H; Zielonka S
Methods Mol Biol; 2018; 1701():147-167. PubMed ID: 29116504
[TBL] [Abstract][Full Text] [Related]
3. Semi-synthetic vNAR libraries screened against therapeutic antibodies primarily deliver anti-idiotypic binders.
Könning D; Rhiel L; Empting M; Grzeschik J; Sellmann C; Schröter C; Zielonka S; Dickgießer S; Pirzer T; Yanakieva D; Becker S; Kolmar H
Sci Rep; 2017 Aug; 7(1):9676. PubMed ID: 28852148
[TBL] [Abstract][Full Text] [Related]
4. Construction of Histidine-Enriched Shark IgNAR Variable Domain Antibody Libraries for the Isolation of pH-Sensitive vNAR Fragments.
Könning D; Hinz S; Grzeschik J; Schröter C; Krah S; Zielonka S; Kolmar H
Methods Mol Biol; 2018; 1827():109-127. PubMed ID: 30196494
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies for the identification and purification of vNAR domains and IgNAR immunoglobulins from the horn shark Heterodontus francisci.
Juarez K; Dubberke G; Lugo P; Koch-Nolte F; Buck F; Haag F; Licea A
Hybridoma (Larchmt); 2011 Aug; 30(4):323-9. PubMed ID: 21851231
[TBL] [Abstract][Full Text] [Related]
6. Construction of Semisynthetic Shark vNAR Yeast Surface Display Antibody Libraries.
Kolmar H; Grzeschik J; Könning D; Krah S; Zielonka S
Methods Mol Biol; 2023; 2702():227-243. PubMed ID: 37679622
[TBL] [Abstract][Full Text] [Related]
7. Transcriptomic analysis of immunoglobulin novel antigen receptor (IgNAR) heavy chain constant domains of brownbanded bamboo shark (Chiloscyllium punctatum).
De Silva DPN; Tan E; Mizuno N; Hosoya S; Reza MS; Watabe S; Kinoshita S; Asakawa S
Fish Shellfish Immunol; 2019 Jan; 84():370-376. PubMed ID: 30291985
[TBL] [Abstract][Full Text] [Related]
8. Structural insights and biomedical potential of IgNAR scaffolds from sharks.
Zielonka S; Empting M; Grzeschik J; Könning D; Barelle CJ; Kolmar H
MAbs; 2015; 7(1):15-25. PubMed ID: 25523873
[TBL] [Abstract][Full Text] [Related]
9. Specific Targeting of Lymphoma Cells Using Semisynthetic Anti-Idiotype Shark Antibodies.
Macarrón Palacios A; Grzeschik J; Deweid L; Krah S; Zielonka S; Rösner T; Peipp M; Valerius T; Kolmar H
Front Immunol; 2020; 11():560244. PubMed ID: 33324393
[TBL] [Abstract][Full Text] [Related]
10. Isolation of a pH-Sensitive IgNAR Variable Domain from a Yeast-Displayed, Histidine-Doped Master Library.
Könning D; Zielonka S; Sellmann C; Schröter C; Grzeschik J; Becker S; Kolmar H
Mar Biotechnol (NY); 2016 Apr; 18(2):161-7. PubMed ID: 26838965
[TBL] [Abstract][Full Text] [Related]
11. Shark New Antigen Receptor (IgNAR): Structure, Characteristics and Potential Biomedical Applications.
Juma SN; Gong X; Hu S; Lv Z; Shao J; Liu L; Chen G
Cells; 2021 May; 10(5):. PubMed ID: 34066890
[TBL] [Abstract][Full Text] [Related]
12. Generation of VNAR Libraries from Immunized Sharks and Selection of Target-Specific Clones.
Dooley H
Methods Mol Biol; 2022; 2421():57-72. PubMed ID: 34870811
[TBL] [Abstract][Full Text] [Related]
13. Shark Attack: high affinity binding proteins derived from shark vNAR domains by stepwise in vitro affinity maturation.
Zielonka S; Weber N; Becker S; Doerner A; Christmann A; Christmann C; Uth C; Fritz J; Schäfer E; Steinmann B; Empting M; Ockelmann P; Lierz M; Kolmar H
J Biotechnol; 2014 Dec; 191():236-45. PubMed ID: 24862193
[TBL] [Abstract][Full Text] [Related]
14. Exploring shark VNAR antibody against infectious diseases using phage display technology.
Lim HT; Kok BH; Leow CY; Leow CH
Fish Shellfish Immunol; 2023 Sep; 140():108986. PubMed ID: 37541634
[TBL] [Abstract][Full Text] [Related]
15. Preparation of Immune and Synthetic VNAR Libraries as Sources of High-Affinity Binders.
Gasperin-Bulbarela J; Cabanillas-Bernal O; Dueñas S; Licea-Navarro AF
Methods Mol Biol; 2022; 2446():71-93. PubMed ID: 35157269
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and therapeutic potential of shark variable new antigen receptor (VNAR) single domain antibody.
Cheong WS; Leow CY; Abdul Majeed AB; Leow CH
Int J Biol Macromol; 2020 Mar; 147():369-375. PubMed ID: 31926922
[TBL] [Abstract][Full Text] [Related]
17. Isolation of highly selective IgNAR variable single-domains against a human therapeutic Fc scaffold and their application as tailor-made bioprocessing reagents.
Buschhaus MJ; Becker S; Porter AJ; Barelle CJ
Protein Eng Des Sel; 2019 Dec; 32(9):385-399. PubMed ID: 32119084
[TBL] [Abstract][Full Text] [Related]
18. Ancient species offers contemporary therapeutics: an update on shark V
English H; Hong J; Ho M
Antib Ther; 2020 Jan; 3(1):1-9. PubMed ID: 32118195
[TBL] [Abstract][Full Text] [Related]
19. Antigen specific VNAR screening in whitespotted bamboo shark (Chiloscyllium plagiosum) with next generation sequencing.
Zhong B; Sun S; Luo Z; Yang J; Jia L; Zheng K; Tang W; Jiang X; Lyu Z; Chen J; Chen G
Fish Shellfish Immunol; 2024 Jul; 150():109661. PubMed ID: 38821227
[TBL] [Abstract][Full Text] [Related]
20. In Vitro Maturation of a Humanized Shark VNAR Domain to Improve Its Biophysical Properties.
Steven J; Ubah OC; Buschhaus M; Kovaleva M; Ferguson L; Porter AJ; Barelle CJ
Methods Mol Biol; 2020; 2070():115-142. PubMed ID: 31625093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
